Dataset Information

Intra-session and inter-subject variability of 3D-FID-MRSI using single-echo volumetric EPI navigators at 3T.

ABSTRACT: PURPOSE:In this study, we demonstrate the first combination of 3D FID proton MRSI and spatial encoding via concentric-ring trajectories (CRTs) at 3T. FID-MRSI has many benefits including high detection sensitivity, in particular for J-coupled metabolites (e.g., glutamate/glutamine). This makes it highly attractive, not only for clinical, but also for, potentially, functional MRSI. However, this requires excellent reliability and temporal stability. We have, therefore, augmented this 3D-FID-MRSI sequence with single-echo, imaging-based volumetric navigators (se-vNavs) for real-time motion/shim-correction (SHMOCO), which is 2× quicker than the original double-echo navigators (de-vNavs), hence allowing more efficient integration also in short-TR sequences. METHODS:The tracking accuracy (position and B0 -field) of our proposed se-vNavs was compared to the original de-vNavs in phantoms (rest and translation) and in vivo (voluntary head rotation). Finally, the intra-session stability of a 5:40 min 3D-FID-MRSI scan was evaluated with SHMOCO and no correction (NOCO) in 5 resting subjects. Intra/inter-subject coefficients of variation (CV) and intra-class correlations (ICC) over the whole 3D volume and in selected regions of interest ROI were assessed. RESULTS:Phantom and in vivo scans showed highly consistent tracking performance for se-vNavs compared to the original de-vNavs, but lower frequency drift. Up to ~30% better intra-subject CVs were obtained for SHMOCO (P < 0.05), with values of 9.3/6.9/6.5/7.8% over the full VOI for Glx/tNAA/tCho/m-Ins ratios to tCr. ICCs were good-to-high (91% for Glx/tCr in motor cortex), whereas the inter-subject variability was ~11-19%. CONCLUSION:Real-time motion/shim corrected 3D-FID-MRSI with time-efficient CRT-sampling at 3T allows reliable, high-resolution metabolic imaging that is fast enough for clinical use and even, potentially, for functional MRSI.

SUBMITTER: Moser P

PROVIDER: S-EPMC7065144 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Intra-session and inter-subject variability of 3D-FID-MRSI using single-echo volumetric EPI navigators at 3T.

Moser Philipp P Eckstein Korbinian K Hingerl Lukas L Weber Michael M Motyka Stanislav S Strasser Bernhard B van der Kouwe Andre A Robinson Simon S Trattnig Siegfried S Bogner Wolfgang W

Magnetic resonance in medicine 20191113 6

<h4>Purpose</h4>In this study, we demonstrate the first combination of 3D FID proton MRSI and spatial encoding via concentric-ring trajectories (CRTs) at 3T. FID-MRSI has many benefits including high detection sensitivity, in particular for J-coupled metabolites (e.g., glutamate/glutamine). This makes it highly attractive, not only for clinical, but also for, potentially, functional MRSI. However, this requires excellent reliability and temporal stability. We have, therefore, augmented this 3D-F ...[more]

PMID: 31721294

Similar Datasets

Project description:PurposeA properly characterized macromolecular (MM) contribution is essential for accurate metabolite quantification in FID-MRSI. MM information can be included into the fitting model as a single component or parameterized and included over several individual MM resonances, which adds flexibility when pathologic changes are present but is prone to potential overfitting. This study investigates the effects of different MM models on MRSI reproducibility.MethodsClinically feasible, high-resolution FID-MRSI data were collected in ~5 min at 7 Tesla from 10 healthy volunteers and quantified via LCModel (version 6.3) with 3 basis sets, each with a different approach for how the MM signal was handled: averaged measured whole spectrum (full MM), 9 parameterized components (param MM) with soft constraints to avoid overparameterization, or without any MM information included in the fitting prior knowledge. The test-retest reproducibility of MRSI scans was assessed voxel-wise using metabolite coefficients of variation and intraclass correlation coefficients and compared between the basis sets. Correlations of concentration estimates were investigated for the param MM fitting model.ResultsThe full MM model provided the most reproducible quantification of total NAA, total Cho, myo-inositol, and glutamate + glutamine ratios to total Cr (coefficients of variations ≤ 8%, intraclass correlation coefficients ≥ 0.76). Using the param MM model resulted in slightly lower reproducibility (up to +3% higher coefficients of variations, up to -0.1 decreased intraclass correlation coefficients). The quantification of the parameterized macromolecules did not affect quantification of the overlapping metabolites.ConclusionClinically feasible FID-MRSI with an experimentally acquired MM spectrum included in prior knowledge provides highly reproducible quantification for the most common neurometabolites in healthy volunteers. Parameterization of the MM spectrum may be preferred as a compromise between quantification accuracy and reproducibility when the MM content is expected to be pathologically altered.

Project description:ObjectivesSuccessful neurosurgical intervention in gliomas depends on the precision of the preoperative definition of the tumor and its margins since a safe maximum resection translates into a better patient outcome. Metabolic high-resolution imaging might result in improved presurgical tumor characterization, and thus optimized glioma resection. To this end, we validated the performance of a fast high-resolution whole-brain 3D-magnetic resonance spectroscopic imaging (MRSI) method at 7T in a patient cohort of 23 high-grade gliomas (HGG).Materials and methodsWe preoperatively measured 23 patients with histologically verified HGGs (17 male, 8 female, age 53 ± 15) with an MRSI sequence based on concentric ring trajectories with a 64 × 64 × 39 measurement matrix, and a 3.4 × 3.4 × 3.4 mm3 nominal voxel volume in 15 min. Quantification used a basis-set of 17 components including N-acetyl-aspartate (NAA), total choline (tCho), total creatine (tCr), glutamate (Glu), glutamine (Gln), glycine (Gly) and 2-hydroxyglutarate (2HG). The resultant metabolic images were evaluated for their reliability as well as their quality and compared to spatially segmented tumor regions-of-interest (necrosis, contrast-enhanced, non-contrast enhanced + edema, peritumoral) based on clinical data and also compared to histopathology (e.g., grade, IDH-status).ResultsEighteen of the patient measurements were considered usable. In these patients, ten metabolites were quantified with acceptable quality. Gln, Gly, and tCho were increased and NAA and tCr decreased in nearly all tumor regions, with other metabolites such as serine, showing mixed trends. Overall, there was a reliable characterization of metabolic tumor areas. We also found heterogeneity in the metabolic images often continued into the peritumoral region. While 2HG could not be satisfyingly quantified, we found an increase of Glu in the contrast-enhancing region of IDH-wildtype HGGs and a decrease of Glu in IDH1-mutant HGGs.ConclusionsWe successfully demonstrated high-resolution 7T 3D-MRSI in HGG patients, showing metabolic differences between tumor regions and peritumoral tissue for multiple metabolites. Increases of tCho, Gln (related to tumor metabolism), Gly (related to tumor proliferation), as well as decreases in NAA, tCr, and others, corresponded very well to clinical tumor segmentation, but were more heterogeneous and often extended into the peritumoral region.

Dataset Information

Intra-session and inter-subject variability of 3D-FID-MRSI using single-echo volumetric EPI navigators at 3T.

Publications

Intra-session and inter-subject variability of 3D-FID-MRSI using single-echo volumetric EPI navigators at 3T.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure